{"id":3142,"date":"2026-02-15T16:28:19","date_gmt":"2026-02-15T16:28:19","guid":{"rendered":"https:\/\/rendergh.net\/?p=3142"},"modified":"2026-02-15T16:28:19","modified_gmt":"2026-02-15T16:28:19","slug":"planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts","status":"publish","type":"post","link":"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/","title":{"rendered":"Planned U.S.-Funded Baby Vaccine Trial in Guinea-Bissau Draws Global Fire from WHO, Ethics Experts"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#An_international_outcry_over_research_ethics_shines_a_spotlight_on_scientific_standards_in_global_health\" >An international outcry over research ethics shines a spotlight on scientific standards in global health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#Proposed_Trial_Background_and_Core_Design\" >Proposed Trial: Background and Core Design<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#WHO_Response_Ethical_and_Scientific_Concerns\" >WHO Response: Ethical and Scientific Concerns<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#Guinea-Bissau_Government_Weighs_Suspension\" >Guinea-Bissau Government Weighs Suspension<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#Scientific_Debate_Risk_Evidence_and_Research_Ethics\" >Scientific Debate: Risk, Evidence, and Research Ethics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#Broader_Global_Health_Implications\" >Broader Global Health Implications<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#Ethical_Standards_and_Research_Oversight\" >Ethical Standards and Research Oversight<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#Next_Steps_Review_Dialogue_and_Global_Coordination\" >Next Steps: Review, Dialogue, and Global Coordination<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/rendergh.net\/fr\/planned-u-s-funded-baby-vaccine-trial-in-guinea-bissau-draws-global-fire-from-who-ethics-experts\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n<h2 data-start=\"648\" data-end=\"755\"><span class=\"ez-toc-section\" id=\"An_international_outcry_over_research_ethics_shines_a_spotlight_on_scientific_standards_in_global_health\"><\/span>An international outcry over research ethics shines a spotlight on scientific standards in global health<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"757\" data-end=\"1185\"><strong data-start=\"757\" data-end=\"786\">By [Author Name] \u2013 [Date]<\/strong><br data-start=\"786\" data-end=\"789\" \/><em data-start=\"789\" data-end=\"819\">Geneva \/ Bissau \/ Copenhagen<\/em> \u2013 A proposed U.S.-funded clinical trial involving newborn infants in the West African nation of <strong data-start=\"916\" data-end=\"933\">Guinea-Bissau<\/strong> has been sharply condemned by the <strong data-start=\"968\" data-end=\"1003\">World Health Organization (WHO)<\/strong> and other global health authorities, sparking intense debate over research ethics, vaccine policy, and international scientific responsibility.<\/p>\n<p data-start=\"1187\" data-end=\"1654\">The controversy reached a peak in mid-February 2026, when WHO officials publicly criticized the study\u2019s design and ethical grounding, calling it \u201cunethical\u201d because it would withhold a widely accepted, life-saving vaccine from some newborns. As Guinea-Bissau\u2019s government announced a temporary suspension of the trial, health professionals and policy makers around the world weighed in on the implications of testing protocols, public trust, and global health equity.<\/p>\n<hr data-start=\"1656\" data-end=\"1659\" \/>\n<h2 data-start=\"1661\" data-end=\"1706\"><span class=\"ez-toc-section\" id=\"Proposed_Trial_Background_and_Core_Design\"><\/span>Proposed Trial: Background and Core Design<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"relative overflow-hidden transition-[max-height,opacity] duration-300 ease-out mt-1 mb-5 [&amp;:not(:first-child)]:mt-4\" aria-hidden=\"false\">\n<div>\n<div class=\"no-scrollbar flex min-h-36 flex-nowrap gap-0.5 overflow-auto sm:gap-1 sm:overflow-hidden xl:min-h-44\">\n<div class=\"border-token-border-default relative w-32 shrink-0 overflow-hidden rounded-xl border-[0.5px] md:shrink max-h-64 sm:w-[calc((100%-0.5rem)\/3)] rounded-s-xl\">\n<div><img decoding=\"async\" class=\"bg-token-main-surface-tertiary m-0 h-full w-full object-cover\" src=\"https:\/\/ichef.bbci.co.uk\/news\/480\/cpsprodpb\/6df3\/live\/5a9712a0-09a5-11f1-90a0-33c579c60bf0.jpg.webp\" alt=\"https:\/\/ichef.bbci.co.uk\/news\/480\/cpsprodpb\/6df3\/live\/5a9712a0-09a5-11f1-90a0-33c579c60bf0.jpg.webp\" \/><\/div>\n<\/div>\n<div class=\"border-token-border-default relative w-32 shrink-0 overflow-hidden rounded-xl border-[0.5px] md:shrink max-h-64 sm:w-[calc((100%-0.5rem)\/3)]\">\n<div><img decoding=\"async\" class=\"bg-token-main-surface-tertiary m-0 h-full w-full object-cover\" src=\"https:\/\/www.hepb.org\/assets\/Uploads\/_resampled\/ResizedImageWzEwMDAsNDM1XQ-Infant-Hepatitis-B-Vaccine-Schedules-Chart-High-Res-for-Website-10.png\" alt=\"https:\/\/www.hepb.org\/assets\/Uploads\/_resampled\/ResizedImageWzEwMDAsNDM1XQ-Infant-Hepatitis-B-Vaccine-Schedules-Chart-High-Res-for-Website-10.png\" \/><\/div>\n<\/div>\n<div class=\"border-token-border-default relative w-32 shrink-0 overflow-hidden rounded-xl border-[0.5px] md:shrink max-h-64 sm:w-[calc((100%-0.5rem)\/3)] rounded-e-xl\">\n<div><img decoding=\"async\" class=\"bg-token-main-surface-tertiary m-0 h-full w-full object-cover\" src=\"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/6\/64\/Bandim_Health_Project.JPG\" alt=\"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/6\/64\/Bandim_Health_Project.JPG\" \/><\/div>\n<div class=\"pointer-events-none absolute end-2 bottom-2\">\n<div class=\"flex items-center gap-1 rounded-full px-2 py-1.5 text-white backdrop-blur-md backdrop-brightness-75\"><span class=\"text-xs font-semibold\">4<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"pointer-events-none absolute inset-x-0 bottom-0 z-10 h-12 bg-gradient-to-b from-transparent via-token-bg-primary\/80 to-token-bg-primary transition-opacity duration-300 ease-out opacity-0 delay-200\" aria-hidden=\"true\"><\/div>\n<\/div>\n<p data-start=\"1750\" data-end=\"2163\">At the center of the debate is a planned <strong data-start=\"1791\" data-end=\"1828\">randomized controlled trial (RCT)<\/strong> to study the effects of the <strong data-start=\"1857\" data-end=\"1880\">hepatitis B vaccine<\/strong> when administered at different times after birth. The study was set to take place in Guinea-Bissau, a low-income nation in West Africa, where hepatitis B infection rates are among the highest in the world and pose a severe public health burden.<\/p>\n<p data-start=\"2165\" data-end=\"2618\">The trial, funded in part by the <strong data-start=\"2198\" data-end=\"2255\">U.S. Centers for Disease Control and Prevention (CDC)<\/strong> with a grant of approximately <strong data-start=\"2286\" data-end=\"2302\">$1.6 million<\/strong>, aimed to enroll roughly <strong data-start=\"2328\" data-end=\"2346\">14,000 infants<\/strong>. Half would receive the standard birth dose of the hepatitis B vaccine within 24 hours of birth, while the remainder would receive their first dose at six weeks of age \u2014 consistent with Guinea-Bissau\u2019s existing immunization schedule.<\/p>\n<p data-start=\"2620\" data-end=\"3110\">Proponents said the study was intended to explore whether the timing of the vaccine has broader effects on early-life health outcomes, including mortality, morbidity, and developmental trajectories. Those proposing the study \u2014 led by researchers associated with the <strong data-start=\"2886\" data-end=\"2911\">Bandim Health Project<\/strong> at the <strong data-start=\"2919\" data-end=\"2953\">University of Southern Denmark<\/strong> \u2014 have described it as an opportunity to build evidence on non-specific health impacts associated with vaccine timing.<\/p>\n<hr data-start=\"3112\" data-end=\"3115\" \/>\n<h2 data-start=\"3117\" data-end=\"3165\"><span class=\"ez-toc-section\" id=\"WHO_Response_Ethical_and_Scientific_Concerns\"><\/span>WHO Response: Ethical and Scientific Concerns<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"3167\" data-end=\"3254\">Such objectives drew swift and fierce criticism from the <strong data-start=\"3224\" data-end=\"3253\">World Health Organization<\/strong>.<\/p>\n<p data-start=\"3256\" data-end=\"3791\">On <strong data-start=\"3259\" data-end=\"3279\">13 February 2026<\/strong>, the WHO released a detailed statement asserting that the hepatitis B birth dose is a \u201cproven, effective, and essential public health intervention\u201d that has been safely used for decades and included in the immunization schedules of more than 115 countries worldwide. In WHO\u2019s view, withholding this intervention from newborns without strong scientific justification exposed infants to \u201cpotentially irreversible harm,\u201d including chronic infection, liver disease, and cancer.<\/p>\n<p data-start=\"3793\" data-end=\"4149\">WHO Director-General <strong data-start=\"3814\" data-end=\"3848\">Dr. Tedros Adhanom Ghebreyesus<\/strong> went further, publicly calling the planned trial \u201cunethical\u201d on scientific and ethical grounds. He argued that trials involving children must meet strict ethical standards and must never deny participants access to interventions known to prevent serious disease.<\/p>\n<p data-start=\"4151\" data-end=\"4533\">The organization noted that hepatitis B transmission at birth accounts for most lifelong infections globally, with each exposed infant facing a high probability of becoming chronically infected if unvaccinated. In Guinea-Bissau, where adult infection rates exceed 12% according to WHO estimates, the birth dose is a critical preventive measure.<\/p>\n<p data-start=\"4535\" data-end=\"4924\">WHO\u2019s statement emphasized the absence of any credible evidence suggesting safety concerns about the vaccine that would justify an RCT withholding care from some participants. It also flagged potential bias in the study\u2019s design, stating the single-blind, no-treatment control approach could limit the interpretability and policy relevance of results.<\/p>\n<hr data-start=\"4926\" data-end=\"4929\" \/>\n<h2 data-start=\"4931\" data-end=\"4976\"><span class=\"ez-toc-section\" id=\"Guinea-Bissau_Government_Weighs_Suspension\"><\/span>Guinea-Bissau Government Weighs Suspension<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"4978\" data-end=\"5396\">In the wake of global criticism and growing local concern, authorities in Guinea-Bissau announced a <strong data-start=\"5078\" data-end=\"5092\">suspension<\/strong> of the trial in late January 2026 pending further ethical and technical evaluation. The government said the country\u2019s National Ethics Committee lacked the technical resources to fully assess the protocol, and that more consultation was needed before moving forward.<\/p>\n<p data-start=\"5398\" data-end=\"5802\">Officials stressed the suspension was not necessarily a cancellation but a necessary pause to ensure that research governance aligns with both domestic oversight and international standards. Media reports suggest that confusion over the country\u2019s vaccine policy transition \u2014 from six-week to birth-dose administration \u2014 has contributed to the oversight challenges.<\/p>\n<p data-start=\"5804\" data-end=\"6069\">Local health experts and former officials have voiced dismay over the plans, with some quoting sentiments such as \u201cWe are not guinea pigs\u201d \u2014 reflecting broader public anxiety about foreign-led research among some communities.<\/p>\n<hr data-start=\"6071\" data-end=\"6074\" \/>\n<h2 data-start=\"6076\" data-end=\"6133\"><span class=\"ez-toc-section\" id=\"Scientific_Debate_Risk_Evidence_and_Research_Ethics\"><\/span>Scientific Debate: Risk, Evidence, and Research Ethics<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"6135\" data-end=\"6515\">Supporters of the study maintain that the trial was approved by Guinea-Bissau\u2019s ethics committee and argue that no child would be deprived of vaccines they would otherwise receive under the current national schedule. As they describe it, the study seeks to compare standard care \u2014 which delays the birth dose \u2014 with an accelerated schedule.<\/p>\n<p data-start=\"6517\" data-end=\"7016\">However, critics argue this logic does not resolve the ethical problem. They contend that because hepatitis B vaccine at birth is globally accepted as best practice and Guinea-Bissau itself plans to adopt it nationwide by 2028, withholding it for research purposes undermines ethical standards. According to many public health ethicists, trials should not deliberately assign participants to an inferior standard of care when an effective intervention exists.<\/p>\n<p data-start=\"7018\" data-end=\"7465\">Scientific arguments extend beyond ethics. Some researchers point out that tracking broad health outcomes can be scientifically useful, but only if study design is rigorous and justified by genuine uncertainty \u2014 something many experts say is absent in this case. The WHO, for example, has stated that the study\u2019s justification did not clearly demonstrate a knowledge gap sufficient to risk participant harm.<\/p>\n<hr data-start=\"7467\" data-end=\"7470\" \/>\n<h2 data-start=\"7472\" data-end=\"7509\"><span class=\"ez-toc-section\" id=\"Broader_Global_Health_Implications\"><\/span>Broader Global Health Implications<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"7511\" data-end=\"7689\">The controversy has ignited debates about <strong data-start=\"7553\" data-end=\"7581\">global health governance<\/strong>, <strong data-start=\"7583\" data-end=\"7601\">vaccine policy<\/strong>, and the responsibilities of funders in research taking place in low-resource settings.<\/p>\n<p data-start=\"7691\" data-end=\"8195\">The United States\u2019 role, particularly under the leadership of Health Secretary <strong data-start=\"7770\" data-end=\"7795\">Robert F. Kennedy Jr.<\/strong>, has been a focal point. Kennedy, a controversial figure with a history of questioning vaccine safety, has overseen shifts in U.S. federal vaccine policy, including changes to recommendations for infant hepatitis B vaccination. Some observers see the Guinea-Bissau trial as part of broader policy shifts that diverge from longstanding public health consensus.<\/p>\n<p data-start=\"8197\" data-end=\"8677\">Public health organizations such as UNICEF and Africa CDC have also weighed in, calling for more transparent communication, stronger ethical oversight, and deeper involvement of local health authorities in research decisions. Opinions vary internationally, but many stress the importance of protecting community trust in vaccination programs \u2014 particularly in countries where vaccine hesitancy can already pose a barrier to disease control.<\/p>\n<hr data-start=\"8679\" data-end=\"8682\" \/>\n<h2 data-start=\"8684\" data-end=\"8727\"><span class=\"ez-toc-section\" id=\"Ethical_Standards_and_Research_Oversight\"><\/span>Ethical Standards and Research Oversight<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"8729\" data-end=\"9333\">At the heart of the debate is the principle that clinical research must adhere to strict ethical guidelines, including <strong data-start=\"8848\" data-end=\"8916\">informed consent, scientific necessity, and minimization of risk<\/strong>. International frameworks such as the <strong data-start=\"8955\" data-end=\"8982\">Declaration of Helsinki<\/strong> and the <strong data-start=\"8991\" data-end=\"9062\">Council for International Organizations of Medical Sciences (CIOMS)<\/strong> guidelines establish that participants in trials should not be deprived of interventions known to be safe and effective unless there is compelling scientific reason. Critics say the Guinea-Bissau plan does not meet these criteria.<\/p>\n<p data-start=\"9335\" data-end=\"9747\">Experts argue that withholding a vaccine that prevents a deadly infection \u2014 especially at birth, when children are most vulnerable \u2014 is ethically indefensible unless clear evidence shows a need to test alternatives. Many vaccine specialists fear that poorly justified research could not only harm participants but also erode public confidence in immunization more broadly.<\/p>\n<hr data-start=\"9749\" data-end=\"9752\" \/>\n<h2 data-start=\"9754\" data-end=\"9810\"><span class=\"ez-toc-section\" id=\"Next_Steps_Review_Dialogue_and_Global_Coordination\"><\/span>Next Steps: Review, Dialogue, and Global Coordination<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"9812\" data-end=\"10227\">As of February 2026, the study remains suspended, with health authorities in Guinea-Bissau engaging with WHO, Africa CDC, and other partners to review study design and ethical considerations. WHO issued an offer to support national health authorities in strengthening hepatitis B birth dose delivery, maternal screening, logistical planning, and vaccine supply chain systems.<\/p>\n<p data-start=\"10229\" data-end=\"10485\">Many public health leaders hope this episode will prompt deeper reflection on how scientific research is planned and conducted in low-income settings \u2014 balancing the pursuit of evidence with unwavering commitment to participant safety and community rights.<\/p>\n<hr data-start=\"10487\" data-end=\"10490\" \/>\n<h2 data-start=\"10492\" data-end=\"10505\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"10507\" data-end=\"10882\">The fallout from the planned U.S.-funded hepatitis B vaccine trial in Guinea-Bissau underscores the complex interplay between science, ethics, and global health policy. While research into improved preventive strategies is vital, experts overwhelmingly maintain that such efforts must never compromise basic ethical principles or expose the most vulnerable to avoidable risk.<\/p>\n<p data-start=\"10884\" data-end=\"11116\">As global health actors continue to engage in dialogue and review, one clear message resonates: protecting children\u2019s health \u2014 grounded in evidence, ethics, and equity \u2014 must remain the central aim of any public health intervention.<\/p>\n<div class=\"gsp_post_data\" \r\n\t            data-post_type=\"post\" \r\n\t            data-cat=\"news\" \r\n\t            data-modified=\"120\"\r\n\t            data-created=\"1771172899\"\r\n\t            data-title=\"Planned U.S.-Funded Baby Vaccine Trial in Guinea-Bissau Draws Global Fire from WHO, Ethics Experts\" \r\n\t            data-home=\"https:\/\/rendergh.net\/fr\"><\/div>","protected":false},"excerpt":{"rendered":"<p>An international outcry over research ethics shines a spotlight on scientific standards in global health By [Author Name] \u2013 [Date]Geneva \/ Bissau \/ Copenhagen \u2013 A proposed U.S.-funded clinical trial involving newborn infants in the West African nation of Guinea-Bissau has been sharply condemned by the World Health Organization (WHO) and other global health authorities, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3143,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[137],"tags":[],"class_list":["post-3142","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news"],"_links":{"self":[{"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/posts\/3142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/comments?post=3142"}],"version-history":[{"count":1,"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/posts\/3142\/revisions"}],"predecessor-version":[{"id":3144,"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/posts\/3142\/revisions\/3144"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/media\/3143"}],"wp:attachment":[{"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/media?parent=3142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/categories?post=3142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rendergh.net\/fr\/wp-json\/wp\/v2\/tags?post=3142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}